Eirion Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $43M
Latest Deal Amount
  • Investors
  • 4

Eirion General Information

Description

Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying, thereby enabling patients to get rid of problems like lateral canthal lines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 25-K Olympia Avenue
  • Suite 200
  • Woburn, MA 01801-6399
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eirion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 09-Mar-2021 $43M 0000 Completed Clinical Trials - Phase 2
1. Spin-Off 01-Jan-2016 Completed Startup
To view Eirion’s complete valuation and funding history, request access »

Eirion Executive Team (2)

Name Title Board Seat Contact Info
Jon Edelson MD Chief Executive Officer, Chairman & President
Klaus Theobald Ph.D Chief Research & Development Officer
To view Eirion’s complete executive team members history, request access »

Eirion Board Members (2)

Name Representing Role Since
Barry Kurokawa Self Board Member 000 0000
Jon Edelson MD Eirion Chief Executive Officer, Chairman & President 000 0000
To view Eirion’s complete board members history, request access »

Eirion Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Shanghai Hao Hai Healthcare Corporation Minority 000 0000 000000 0
Praesideo Management Hedge Fund Minority 000 0000 000000 0
Scientific Health Development Venture Capital Minority 000 0000 000000 0
The Spring Bay Companies Venture Capital Minority 000 0000 000000 0
To view Eirion’s complete investors history, request access »